Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Low Anterior Resection Syndrome × Botulinum Toxins, Type A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lower Urinary Tract Symptoms 1 Low Anterior Resection Syndrome 1 Hereditary leiomyomatosis and renal cell cancer 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Agnosia 1

Interventions

Device Removal 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01589471 2018-02-12

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed

Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡